INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC's Holding History (CIK: 0001638555)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 84,515 Value ($000) $5,351 Avg Close Range
Q1 2023
Shares 589 Value ($000) $32 Avg Close Range
Q2 2022
Shares 138,331 Value ($000) $7,896 Avg Close Range
Q1 2022
Shares 239,903 Value ($000) $14,680 Avg Close Range